MALAT1 and prostate cancer: A marginal increase in the early apoptotic cell population was observed in MALAT1-ablated prostate cancer cells compared with their respective shSCRM controls, while upon olaparib treatment the number of apoptotic cells was markedly increased (Fig. 6I and J).